0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Correction   |    
Correction
Am J Psychiatry 2005;162:1042-a-1042.
text A A A

In a letter to the editor in the March issue by Christopher Thomas, Pharm.D., B.C.P.P., titled "Memantine and Catatonic Schizophrenia" (Am J. Psychiatry 2005; 162:626), additional authors should have been listed. They are as follows: Brendan T. Carroll, M.D., Robert T. Maley, Pharm.D., Kameshwari Jayanti, M.D., and Atchuthamba Koduri, M.D.

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
Amantadine and memantine in catatonic schizophrenia. Ann Clin Psychiatry 2006 Apr-Jun;18(2):133-4.